Ozempic costs $349 per month for the 0.25 mg, 0.5 mg, or 1 mg pens, and $499 per month for the 2 mg pen, when purchased through Novo Nordisk’s official self-pay pricing. Without any discount or insurance, the average retail price at pharmacies runs around $1,028 to $1,394 for a 28-day supply. What you actually pay depends heavily on your insurance, your dose, and whether you use a savings program.
Retail Price vs. Self-Pay Price
There are two numbers that matter here, and they’re very different. The retail price, sometimes called the list price, is what pharmacies charge before any discounts. For Ozempic, that averages roughly $1,028 to $1,394 per month depending on the dose and pharmacy. This is the sticker-shock number most people see when they first look up the cost.
Novo Nordisk now offers a direct self-pay price that bypasses insurance entirely: $349 per month for the lower-dose pens (0.25 mg, 0.5 mg, and 1 mg) and $499 per month for the 2 mg pen. A “month” in Ozempic terms means 28 days, so you’d need 13 fills per year rather than 12. Pharmacy discount tools like GoodRx can bring prices down to a similar range, with coupons starting around $199 for certain pen sizes.
The list price also crept up 3% at the start of 2025, part of a broader pattern of annual drug price increases across the pharmaceutical industry.
What You’ll Pay With Insurance
Most commercial insurance plans cover Ozempic for type 2 diabetes, since that’s its FDA-approved use. Your copay depends on where the drug sits on your plan’s formulary. If it’s on a preferred tier, you might pay $25 to $75 per month. If it’s on a specialty tier, copays can climb to $150 or more before any manufacturer discounts kick in.
Insurers typically limit you to one pen per 28 days at retail, or three pens per 84 days through mail-order pharmacy. Prior authorization requirements vary by plan, but coverage is generally straightforward when you have a type 2 diabetes diagnosis. Getting Ozempic covered for weight loss alone is a different story, since most plans don’t cover it for that purpose (Wegovy, which contains the same active ingredient at higher doses, is the version approved for weight management).
Novo Nordisk’s Savings Card
If you have commercial insurance that covers Ozempic, the manufacturer’s savings card can reduce your copay to as little as $25 per month. The card covers up to $100 in savings per fill and lasts up to 48 months. That’s a meaningful discount if your insurance copay would otherwise be $50 to $125.
New patients without insurance get a slightly different deal: $199 per month for the first two months on the 0.25 mg or 0.5 mg starter doses. After that introductory period, the price moves to the standard $349 or $499 depending on dose.
One important exclusion: if you’re on Medicare, Medicaid, or any other government insurance program, you’re not eligible for the savings card. That’s a federal rule that applies to nearly all manufacturer coupon programs, not just Ozempic.
Medicare and Government Coverage
Medicare Part D has historically not covered GLP-1 medications when prescribed solely for weight loss. For type 2 diabetes, Part D plans do cover Ozempic, though your out-of-pocket cost depends on your specific plan’s formulary and which coverage phase you’re in.
A newer development is the Medicare GLP-1 Bridge, a temporary demonstration program running from July 2026 through December 2027. This program covers certain GLP-1 drugs for weight reduction in Medicare beneficiaries, but the eligible medications are Wegovy, Zepbound, and Foundayo, not Ozempic. Separately, Ozempic is part of Medicare’s drug price negotiation program, with a negotiated price set to take effect in January 2027. That negotiated price could significantly reduce what Medicare beneficiaries pay for Ozempic when used for diabetes.
Compounded Semaglutide as a Lower-Cost Option
Compounding pharmacies have offered versions of semaglutide (the active ingredient in Ozempic) at lower prices, typically $200 to $500 per month. These compounded versions became widely available during drug shortages and attracted millions of users looking for a more affordable option.
The compounded market is in flux, though. The FDA has moved to restrict compounded semaglutide now that the brand-name shortage has eased, and availability varies by state and pharmacy. Quality and dosing consistency also differ between compounders. If you’re considering this route, the cost savings can be real, but so are the trade-offs in standardization and long-term availability.
How Dose Affects Your Total Cost
Ozempic treatment starts at 0.25 mg weekly for the first four weeks, then increases to 0.5 mg. Many people eventually move to 1 mg or 2 mg for better blood sugar control. Each step up can change your cost.
At the self-pay price, staying at 0.5 mg or 1 mg keeps you at $349 per 28 days, or roughly $4,537 per year. Moving to the 2 mg dose jumps that to $499 per 28 days, about $6,487 annually. With insurance, the dose change may not affect your copay at all if the drug stays on the same formulary tier. But if your plan charges a percentage-based coinsurance rather than a flat copay, the higher-dose pen will cost you more out of pocket.
One pen covers a full 28-day supply at any dose level. You won’t need multiple pens per month unless your prescriber writes for an unconventional dosing schedule.
Ways to Reduce Your Cost
- Use the manufacturer savings card if you have commercial insurance. It caps your copay at $25 for up to four years.
- Compare pharmacy prices using GoodRx or similar tools. Prices vary significantly between pharmacies, sometimes by hundreds of dollars for the same pen.
- Ask about mail-order pharmacy through your insurance. Filling a 90-day supply often comes with a lower per-month cost than filling monthly at retail.
- Check Novo Nordisk’s self-pay pricing if you’re uninsured. At $349 per month for most doses, it’s substantially cheaper than the retail list price.
- Look into patient assistance programs if your household income qualifies. Novo Nordisk runs a program for eligible uninsured patients that can provide the medication at no cost.